D-0485-2015 Class II Terminated

Recalled by Noven Pharmaceuticals, Inc. — Miami, FL

FDA drug recall D-0485-2015 was initiated by Noven Pharmaceuticals, Inc. on Feb 25, 2015 and is designated Class II. Reason for recall: Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions. The recall status is terminated (terminated Feb 26, 2019). Affected quantity: 720 transdermal patches.

Recall Details

Product Type
Drugs
Report Date
Apr 22, 2015
Initiation Date
Feb 25, 2015
Termination Date
Feb 26, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
720 transdermal patches

Product Description

Minivelle (estradiol transdermal system) 0.05 mg/day, 8-count box, Rx only, Manufactured by Noven Pharmaceuticals, Inc., Miami, Florida 33186, Distributed by Noven Pharmaceuticals, LLC, Miami, Florida 33186, NDC 68968-6650-8

Reason for Recall

Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.

Distribution Pattern

Nationwide

Code Information

Lot # 76476; Exp 07/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0485-2015
openFDA file date
Oct 26, 2026
Loaded by RegDataLab
Oct 27, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.